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Abstract
Fanconi anemia (FA) pathway genes are important tumor suppressors whose best-characterized 
function is repair of damaged nuclear DNA. Herein, we describe an essential role for FA genes in 
two forms of selective autophagy. Genetic deletion of Fancc blocks the autophagic clearance of 
viruses (virophagy) and increases susceptibility to lethal viral encephalitis. FANCC interacts with 
Parkin; is required in vitro and in vivo for clearance of damaged mitochondria; and decreases 
mitochondrial ROS production and inflammasome activation. The mitophagy function of FANCC 
is genetically distinct from its role in genomic DNA damage repair. Moreover, additional genes in 
the FA pathway, including FANCA, FANCF, FANCL, FANCD2, BRCA1 and BRCA2, are 
required for mitophagy. Thus, members of the FA pathway represent a previously undescribed 
class of selective autophagy genes that function in immunity and organellar homeostasis. These 
findings have implications for understanding the pathogenesis of FA and cancers associated with 
mutations in FA genes.
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INTRODUCTION
Homozygous or compound heterozygous loss-of-function mutations in any of ~19 genes of 
the Fanconi Anemia (FA) pathway lead to a spectrum of clinical disorders, including birth 
defects, cognitive impairment, bone marrow failure, cancer and premature aging (Bogliolo 
and Surralles, 2015; Neveling et al., 2009). Although FA is rare, somatic mutations or 
epigenetic silencing of FA genes are commonly found in sporadic cancers, particularly of the 
breast, ovaries, and pancreas (D'Andrea, 2010). Moreover, heterozygous germline mutations 
in at least five genes in the FA pathway, BRCA2/FANCD1, BRIP1/FANCJ, PALB2/
FANCN, RAD51C/FANCO, and BRCA1/FANCS, are important cancer risk alleles 
(Bogliolo and Surralles, 2015).
The best characterized function of FA genes is genomic DNA damage repair – specifically 
the repair of DNA interstrand crosslinks formed in the presence of endogenous ROS or 
aldehyde substrates (Garaycoechea and Patel, 2014). In response to DNA crosslinker 
damage, eight FA proteins assemble to form the FA core complex containing the E3 
ubiquitin ligase FANCL, which mono-ubiquitinates FANCD2 and FANCI in the nucleus and 
thereby orchestrates downstream DNA repair (Garaycoechea and Patel, 2014). Some FA 
proteins also have cytoplasmic functions, such as protection from proinflammatory cytokine-
induced cell death (Haneline et al., 1998), maintenance of mitochondrial respiratory 
function, suppression of intracellular ROS levels (Pagano et al., 2013), and reduction of 
inflammasome activity (Garbati et al., 2013).
The mechanism(s) by which FA proteins function in cytoplasmic processes and the extent to 
which such processes can be separated from genomic DNA repair activity are poorly 
understood. However, a naturally occurring hypomorphic mutant of FANCC (c.67delG) 
encodes a shorter protein lacking the FANCC N-terminal 55 amino acids and fully 
complements the cytoprotective but not the genomic DNA repair functions in FANCC null 
mutant cells (Bagby and Alter, 2006). FANCC-deficient patients with at least one FANCC c.
67delG allele have fewer congenital abnormalities and a milder clinical phenotype when 
compared to FA patients without any detectable FANCC protein (Yamashita et al., 1996). 
This suggests that DNA repair-independent functions of FANCC (and perhaps other FA 
genes) may play a crucial role in the pathophysiology of FA and/or cancers that occur in the 
setting of mutations in FA genes.
Three FA genes, FANC, FANCF and FANCL, were identified in a genome-wide screen as 
candidate selective autophagy factors (Orvedahl et al., 2011). Selective autophagy is a 
homeostatic process that targets unwanted cellular cargo to autophagosomes with 
subsequent degradation in autolysosomes (Rogov et al., 2014). Diverse cargos have been 
recognized as substrates for selective autophagy, including damaged mitochondria 
(mitophagy) and viruses (virophagy). Selectivity is achieved through autophagy receptors 
(such as p62, NBR1, NDP52, and optineurin), which recognize cargos tagged with 
degradation signals as well as the autophagosomal membrane protein LC3. Although 
multiple autophagy receptors, as well as ubiquitin ligases such as Parkin (which mediates the 
ubiquitination of damaged mitochondria and intracellular bacteria) have been identified 
(Rogov et al., 2014), it is likely that other factors are involved in selective autophagy.
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Defects in selective autophagy have profound effects on organismal biology, including 
several that overlap with effects of mutations in FA pathway genes. Both mutations in core 
autophagy genes that function in autophagosome membrane formation and mutations in 
mitophagy-specific genes promote tumorigenesis through a mechanism thought to involve 
failure to remove damaged mitochondria and subsequent increases in mitochondrial ROS 
(mtROS) and genotoxic stress (Chourasia et al., 2015). Deletion of essential autophagy 
genes in hematopoietic stem cells (HSCs) results in bone marrow failure characterized by 
accumulation of damaged mitochondria and mtROS (Mortensen et al., 2011) and defective 
mitophagy results in enhanced inflammasome-mediated IL-1 β secretion (Nakahira et al., 
2011; Zhou et al., 2011).
We therefore hypothesized that FA genes may function in selective autophagy, and that such 
a role may represent a previously undescribed function that could contribute to the 
pathogenesis of congenital FA and of cancers that occur in patients with germline or somatic 
FA gene mutations. Our data demonstrate that FA genes function in the selective autophagy 
of genetically distinct viruses, in mitochondrial quality control, and in preventing 
inflammasome activation due to mtROS. Moreover, we show that the activity of FANCC in 
mitophagy is independent of its role in nuclear DNA damage repair. These findings have 
important implications for understanding the mechanisms by which mutations in FA genes 
contribute to human disease.
RESULTS
FANCC is required for virophagy but not for starvation-induced autophagy
FANCC, FANCF and FANCL were identified in a genome-wide siRNA screen as potential 
selective autophagy factors (Orvedahl et al., 2011). We focused on FANCC, as its role in 
cytokine hypersensitivity is independent of its function in nuclear DNA damage repair (Pang 
et al., 2001) and as Fancc knockout mice exhibit increased susceptibility to bone marrow 
failure when exposed to proinflammatory cytokines or endotoxin (Haneline et al., 1998; 
Parmar et al., 2009). To determine whether FANCC is a selective autophagy factor, we used 
siRNAs targeting FANCC and murine embryonic fibroblasts (MEFs) derived from Fancc−/− 
mice and Fancc+/+ littermate controls.
First, we evaluated whether Fancc is required for starvation-induced autophagy, a form of 
nonselective autophagy (Mizushima and Komatsu, 2011). Fancc−/− and Fancc+/+ MEFs did 
not differ in starvation-induced autophagic flux, as measured by the conversion of the non-
lipidated form of LC3 (LC3-I) to the lipidated, autophagosome-associated form, LC3-II, in 
the presence and absence of the lysosomal inhibitor bafilomycin A1 (Baf A1) (Figure 1A) or 
by the degradation of the autophagy substrate p62 (Figure 1B). The numbers of GFP-LC3 
puncta (a marker of autophagosomes) (Mizushima et al., 2010) were not decreased during 
basal or starvation conditions in MEFs derived from Fancc−/− mice crossed to GFP-LC3 
transgenic mice (Mizushima et al., 2004) (Fancc−/−/GFP-LC3) compared to wild-type (WT) 
(Fancc+/+/GFP-LC3) controls (Figure 1C). There was also no difference in GFP-LC3 puncta 
in the presence of Baf A1, confirming that Fancc is not required for starvation-induced 
autophagic flux. Upon ultrastructural analysis, Fancc−/− and Fancc+/+ MEFs had a similar 
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robust increase in autophagosomes and autolysosomes in response to starvation (Figure 1D). 
Thus, Fancc deficiency in MEFs does not impair starvation-induced autophagy.
We then evaluated whether Fancc is required for virophagy (Sumpter and Levine, 2011). We 
used two neuronotropic viruses, Sindbis virus (SIN), a positive-strand RNA virus in the 
Togaviridae family, and a herpes simplex virus type 1 mutant strain HSV-1 ICP34.5Δ68-87 
(Orvedahl et al., 2007), a DNA virus genetically engineered to lack autophagy inhibitory 
activity. This mutant virus contains a 20 amino acid deletion in the neurovirulence protein 
ICP34.5 which abrogates its inhibition of the essential autophagy protein, Beclin 1 and 
blocks HSV-1 neurovirulence in WT mice (Orvedahl et al., 2007). We chose these viruses 
because they are targeted for autophagic degradation (Sumpter and Levine, 2011) and 
because autophagic degradation of viral components in neurons is important in antiviral 
defense (Yordy and Iwasaki, 2013).
We confirmed that three siRNAs targeting FANCC decreased FANCC gene expression and 
decreased the colocalization of an mCherry SIN capsid fusion protein with GFP-LC3 in 
HeLa/GFP-LC3 cells infected with the recombinant SIN virus, SIN/mCherry.capsid, as 
efficiently as knockdown of an essential autophagy gene, ATG7 (Mizushima et al., 2010) 
(Figures S1A-S1C). To rule out off-target effects of siRNA, we evaluated SIN capsid and 
GFP-LC3 colocalization in Fancc−/− and Fancc+/+ MEFs infected with SIN-mCherry.capsid/
GFP-LC3 (Orvedahl et al., 2010), a virus genetically engineered to express both an mCherry 
capsid fusion protein and, from a duplicated internal subgenomic promoter, GFP-LC3. 
Fewer colocalized mCherry.capsid and GFP-LC3 puncta were observed in SIN-infected 
Fancc−/− as compared to Fancc+/+ MEFs (Figure 1E and 1F). No differences were observed 
in numbers of mCherry.capsid or GFP-LC3 puncta between the two genotypes (data not 
shown), indicating that this decrease is not due to differences in viral replication or 
autophagosome formation but rather represents a specific defect in targeting SIN 
nucleocapsids to autophagic structures.
We next examined whether FANCC localizes to SIN capsid-containing autophagic 
structures. We generated HeLa FANCCKO cells using the CRISPR/Cas9 system (Figure 1G), 
and performed immunoprecipitation (IP) using an anti-LC3 antibody of the microsomal + 
mitochondrial fractions (Figure S1D) from mechanically lysed SIN-infected HeLa 
FANCCKO cells transduced with a lentivirus expressing empty vector or FANCC-Flag. 
Electron microscopic (EM) analysis of structures IP’d with anti-LC3 revealed numerous 
autophagosomal and autolysosomal vesicles containing SIN nucleocapsids (Figure 1H). 
Western blot analysis of these structures revealed the presence of both FANCC-Flag and SIN 
capsid protein (Figure 1I). FANCC-Flag was contained within these autophagolysosomal 
membrane structures as it was protected from proteinase K-mediated proteolysis and this 
protection was lost upon membrane disruption with detergent (Figure 1J). Moreover, similar 
to previously identified SIN virophagy factors such as p62 and SMURF1 (Orvedahl et al., 
2010; Orvedahl et al., 2011), we found that FANCC-Flag and SIN capsid interact by 
performing co-immunoprecipitation (co-IP) of FANCC-Flag and SIN capsid in SIN-infected 
HeLa FANCCKO/vector and HeLa FANCCKO/FANCC cells subjected to detergent lysis 
(Figure 1K).
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Thus, FANCC-Flag is not only required for SIN viral capsid targeting to GFP-LC3 positive 
structures; it is also present inside SIN capsid-containing autophagic vesicles and interacts 
with SIN capsid protein, consistent with a direct role in targeting SIN capsid for autophagy. 
However, FANCC-Flag is not a classical autophagy adaptor that binds both cargo and LC3 
and/or other Atg8 family members (e.g. GABARAP, GATE-16) as these proteins did not co-
IP with FANCC-Flag in uninfected or SIN-infected cells (Figure S1E). As there are no 
suitable antibodies for IP of endogenous FANCC, we performed IP of another FA core 
complex protein, FANCA (the most commonly mutated protein in FA patients (Bagby and 
Alter, 2006)), and found that endogenous FANCA co-IPs with SIN capsid (Figure S1F).
To determine whether FANCC may have a more generalized role in virophagy, we 
performed EM of Fancc+/+ and Fancc−/− MEFs infected with HSV-1 ICP34.5Δ68-87 (Figure 
1L and 1M). HSV-1 replicates and assembles its nucleocapsids in the nucleus but can be 
captured by autophagosomes during its transit through the cytoplasm (Talloczy et al., 2006). 
In Fancc+/+ MEFs, most HSV-1 nucleocapsids and viral particles were detected (often in a 
partially degraded form) inside autolysosomal structures. In contrast, in Fancc−/− MEFs 
(similar to virophagy-deficient Pkr−/− and Smurf1−/− MEFs (Orvedahl et al., 2011; Talloczy 
et al., 2006)), there were fewer HSV-1-containing autophagosomes/autolysosomes and more 
free nucleocapsids and assembled virions inside in the cytoplasm.
Taken together, these data demonstrate that FANCC is required for virophagy of two 
genetically distinct viruses, SIN (ssRNA genome) and HSV-1 (dsDNA genome), but not for 
starvation-induced autophagy.
FANCC is required for host defense against neuronotropic viruses
To investigate whether Fancc-mediated virophagy is associated with antiviral defense in 
vivo, we studied the pathogenesis of CNS infection in Fancc+/+ and Fancc−/− mice in well-
established animal models of SIN and HSV-1 ICP34.5Δ68-87 infection (Orvedahl et al., 
2007; Orvedahl et al., 2010). Following intracerebral inoculation of one week-old animals 
with SIN (strain dsTE12Q), Fancc−/− mice had increased mortality compared to Fancc+/+ 
littermate controls (Figure 2A). This was associated with an increase in neuronal cell death 
by TUNEL staining (Figure 2B and 2C). Similar to findings in mice lacking neuronal 
expression of the Atg5 autophagy protein (Orvedahl et al., 2010), this increase in cell death 
was accompanied by impaired SIN capsid antigen clearance but not by increases in SIN viral 
titers in the brain (Figure S2A and S2C). Six-eight week-old Fancc−/− mice were also more 
susceptible to lethal CNS infection (following intracerebral inoculation) with HSV-1 
ICP34.5Δ68-87 than were Fancc+/+ or Fancc+/− mice (Figure 2D). The brains of Fancc−/− 
mice had more neuronal death at day 3 after infection and increased HSV-1 antigen at days 3 
and 5 without an increase in CNS viral titers (Figures 2E and 2F, Figures S2B and S2D). 
Fancc−/− mice had no increase in susceptibility to another HSV-1 strain, HSV-1 TK− (Pyles 
and Thompson, 1994), which is neuroattentuated because of a deletion in the viral thymidine 
kinase gene rather than a mutation that affects autophagy (Figure S2E), providing genetic 
evidence that Fancc-mediated antiviral host defense against lethal CNS HSV-1 infection 
involves the autophagy pathway. Thus, taken together, our findings demonstrate that Fancc is 
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required for antiviral host defense against two unrelated viruses in vivo and its antiviral 
effects are likely mediated through autophagy.
FANCC is required for mitophagy in vitro and mitochondrial quality control in vivo
In our previous genome-wide screen, FANCC was required not only for SIN virophagy, but 
also for mitophagy mediated by the E3 ligase Parkin upon treatment with the mitochondrial 
uncoupling agent, CCCP (Orvedahl et al., 2011). We confirmed that siRNA knockdown of 
FANCC blocked CCCP-induced, Parkin-mediated mitophagy as efficiently as knockdown of 
the essential autophagy gene, ATG7 (Figure S3A-S3D). We verified an essential role of 
FANCC in Parkin-mediated mitophagy using parental HeLa cells or HeLa FANCCKO cells 
transduced with a retrovirus expressing HA-Parkin. HeLa FANCCKO/Parkin cells were 
deficient in mitophagy after treatment with a combination of two specific inhibitors of 
mitochondrial respiration, Oligomycin + Anitmycin A, (OA), as measured by quantitation of 
TOMM20 (outer mitochondrial membrane protein) and ATP5B (mitochondrial matrix 
protein) puncta (Figures 3A and 3B) or by western blot detection of TOMM20, HSP60 
(mitochondrial matrix protein) and COXIV (inner mitochondrial membrane protein) (Figure 
3C). To determine whether Fancc deficiency results in a defect in mitochondrial quality 
control in vivo, we performed EM analysis of brains and hearts from one year-old Fancc+/+ 
or Fancc−/− mice (Figure 3D). In Fancc−/− but not Fancc+/+ mice, we observed a marked 
accumulation of abnormal mitochondria. Thus, Fancc is essential for Parkin-dependent 
mitophagy in vitro and for mitochondrial homeostasis in vivo.
We next evaluated whether Parkin expression affects the subcellular localization of FANCC 
and mitochondria using HeLa FANCCKO/FANCC cells transduced with a retrovirus 
expressing HA-Parkin (HeLa FANCCKO/FANCC/Parkin). In the absence of Parkin 
expression, little colocalization was observed between FANCC-Flag and the mitochondrial 
marker, TOMM20, even after treatment with OA (Figure 4A, left panels). In the presence of 
Parkin expression and OA, there was a marked increase in FANCC and TOMM20 
colocalization (Figure 4A, right panels). This increase in FANCC and TOMM20 
colocalization was accompanied by an increase in FANCC and Parkin colocalization (Figure 
4B). Furthermore, Parkin co-IP’d with FANCC-Flag in HeLa FANCCKO/FANCC/Parkin 
cells (Figure 4C). Thus, Parkin increases the mitochondrial localization of FANCC during 
OA treatment, colocalizes with FANCC at damaged mitochondria and biochemically 
interacts with FANCC. Although FANCC interacts with Parkin, it does not function as a 
classical mitophagy receptor that binds cargo and LC3, as no interaction was detected 
between FANCC-Flag and Atg8 family proteins in the presence or absence of OA (Figure 
S4A). The interaction between Parkin and FA proteins was not an artifact of ectopic FA 
protein expression, as Parkin interacted with endogenous FANCA in HeLa/Parkin cells, and 
this increased with OA (Figure 4D).
To confirm that FA proteins are present in mitochondria, we isolated highly purified 
mitochondria from HeLa WT/Parkin cells using differential centrifugation followed by anti-
TOMM20 IP of crude mitochondrial fractions (Fig. S4B). We confirmed this approach 
yielded mitochondria by EM evaluation of the anti-TOMM20 immunoprecipitates; the 
mitochondria were intact in the absence of OA but were ruptured in the presence of OA 
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(Figure 4E). Western blot analyses of these anti-TOMM20 immunoprecipitates 
(mitochondria) revealed the presence of other mitochondrial proteins such as HSP60 and 
COXIV and no evidence of nuclear lamin A/C contamination (Figure 4F). With (but not 
without) OA, HA-Parkin was also present in mitochondria isolated from both HeLa WT and 
HeLa FANCCKO cells, suggesting that FANCC is not required for mitochondrial 
localization of Parkin. Moreover, endogenous FANCD2 was present in mitochondrial 
fractions in the presence or absence of FANCC or OA. Unlike nuclear FANCD2 which is 
mono-ubiquitinated in response to treatment with the DNA cross-linking agent, MMC, 
mitochondrial FANCD2 was not mono-ubiquitinated during mitophagy-inducing conditions.
FANCC inhibits mtROS production and inflammasome activation
We evaluated whether fibroblasts from patients with FA exhibit abnormalities in the 
clearance of damaged mitochondria. FANCC mutant patient fibroblasts are deficient in 
FANCD2 mono-ubiquitination when treated with MMC, and this is rescued by retroviral 
transduction of WT FANCC (Figure 5A). In response to CCCP, FANCC patient mutant 
fibroblasts accumulate diffuse fragmented mitochondria as detected by TOMM20 
immunostaining (Figure 5B). This accumulation of damaged mitochondria was associated 
with increased mtROS levels which were rescued by expression of WT FANCC (Figure 5C). 
Thus, FANCC removes damaged mitochondria and decreases levels of mtROS in human 
fibroblasts.
Given the established role of mtROS in inflammasome activation (Tschopp, 2011), we 
hypothesized that increased mtROS generation in FANCC mutant cells leads to enhanced 
inflammasome-dependent cytokine secretion. When we stimulated bone marrow-derived 
macrophages (BMDMs) from Fancc+/+ and Fancc−/− mice with inflammasome activators, 
bacterial lipopolysaccharides (LPS) and ATP (Figure 5D), BMDMs from Fancc−/− mice 
produced more mtROS than BMDMs from WT littermates. BMDMs from Fancc−/− mice 
also secreted more IL-1β than BMDMs from Fancc+/+ mice after LPS + ATP (Figure 5E) 
indicating increased inflammasome activation. This effect was partially reversed by 
MitoTEMPO, a mitochondria-localized oxygen scavenger (Trnka et al., 2009), indicating a 
role for increased mtROS generation in enhanced inflammasome activation in Fancc-
deficient BMDMs.
To confirm that mtROS causes enhanced inflammasome activation in Fancc−/− BMDMs, we 
analyzed an additional readout of inflammasome activation, the ASC speck (Stutz et al., 
2013). The ASC speck is a macromolecular structure consisting of cytoplasmic sensors that 
interact with the adaptor protein ASC, which serves as a scaffold to link sensor(s) with 
caspase-1; inside these structures, caspase-1 processes pro-IL-1β to its mature, secreted form 
(Man et al., 2014). Consistent with our data on IL-1β secretion, cells containing an ASC 
speck were more frequent in Fancc−/− than in Fancc+/+ BMDMs and this was reduced by 
MitoTEMPO (Figure 5F).
To determine whether the elevated levels of mtROS and inflammasome activation in Fancc-
deficient BMDMs are associated with a defect in mitochondrial clearance, we stained the 
mitochondrial matrix protein ATP5B in untreated and LPS-treated Fancc+/+ and Fancc−/− 
BMDMs (LPS + ATP treatment induced cell death too rapidly to allow measurement of 
Sumpter et al. Page 7
Cell. Author manuscript; available in PMC 2017 May 05.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
mitochondrial clearance [data not shown]). At baseline, fragmented mitochondria 
accumulated throughout the cytoplasm in Fancc−/− but not Fancc+/+ BMDMs (Figure S5). 
Following LPS, Fancc+/+ BMDMs had significantly more clearance of mitochondria than 
Fancc−/− BMDMs (Figure 5G and 5H). These observations suggest that Fancc−/− BMDMs 
have a basal defect in mitochondrial quality control and an impaired ability to clear 
mitochondria in response to LPS.
In parallel with the effects of MitoTEMPO on decreased inflammasome activation, Fancc−/− 
BMDMs treated with LPS + ATP had a striking accumulation of large ASC specks which 
colocalized with mitochondria and which decreased in size and number with MitoTEMPO 
treatment (Figure 5F and 5I). Taken together, these findings suggest that the failure to clear 
damaged mitochondria leads to elevated mtROS levels and inflammasome activation in 
Fancc-deficient BMDMs.
The role of FANCC in mitophagy is genetically distinct from its role in nuclear DNA damage 
repair
FANCC-mutated cells carrying a hypomorphic allele of a naturally occurring mutation in 
FANCC, FANCC c.67delG, are not hypersensitive to inflammatory cytokine-induced cell 
death (Pang et al., 2001). However, these cells are still defective in the DNA damage repair 
function of the FA core complex, which is commonly assessed by sensitivity to cell death 
induced by MMC and immunoblot analysis of MMC-induced FANCD2 mono-
ubiquitination. Although FANCC c.67delG partially rescued MMC-induced cell death in a 
previous study, this was an artifact of overexpression as patient cells harboring the FANCC 
c.67delG allele were indistinguishable from patient cells with null alleles for FANCC in the 
MMC-induced cell death assay (Yamashita et al., 1996). Therefore, we used FANCC c.
67delG as a naturally occurring mutant form of FANCC to investigate whether the 
mitophagy function of FANCC is linked to its role in genomic DNA damage repair.
We expressed Flag epitope-tagged WT FANCC or FANCC c.67delG in HeLa FANCCKO 
cells (Figure 6A) and examined cytokine hypersensitivity (Figure 6B), MMC-induced 
FANCD2 mono-ubiquitination (Figure 6A) and cell death (Figure 6C), and Parkin-mediated 
mitophagy (Figure 6D-F). Although FANCC protein levels were lower in FANCCKO cells 
transduced with a vector expressing FANCC c.67delG than WT FANCC (and the protein 
levels of both WT FANCC and FANCC c.67delG were lower than endogenous FANCC 
protein levels) (Figure 6A), FANCC c.67delG rescued cytokine hypersensitivity (as 
measured by cell death in response to TNF-α and IFN-γ) as efficiently as WT FANCC 
(Figure 6B). Although FANCC c.67delG rescued cytokine hypersensitivity, it failed to 
rescue nuclear DNA damage repair functions of FANCC. WT FANCC but not FANCC c.
67delG rescued both MMC-induced FANCD2 mono-ubiquitination (Figure 6A) and cell 
death (Figure 6C), confirming that the FANCC c.67delG mutant is a null allele for the 
genomic DNA repair function of the FA pathway.
In FANCCKO cells expressing FANCC c.67delG, Parkin-mediated mitochondrial clearance 
after OA treatment (measured by quantitative image analysis of TOMM20 and ATP5B 
puncta and western blot analysis of HSP60 and TOMM20) was equal to or greater than in 
FANCCKO cells expressing WT FANCC (Figures 6D-G, Figure S6). Thus, the mitophagy 
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function of FANCC segregates with its role in cytokine hypersensitivity rather than its role 
in genomic DNA damage repair.
Multiple Fanconi anemia genes are required for mitophagy
To evaluate whether selective autophagy represents a function of FA pathway genes other 
than FANCC, we evaluated Parkin-mediated mitophagy in HeLa cells with knockdown of 
additional FA core complex genes, including FANCA, FANCF and FANCL, as well as 
FANCD2, BRCA1/FANCS, and BRCA2/FANCD1, which coordinate the repair of genomic 
DNA (Bagby and Alter, 2006). We confirmed that all four siRNAs targeting FANCF and 
FANCL used in our previous screen (Orvedahl et al. 2011) decreased CCCP-induced Parkin-
dependent clearance of TOMM20-positive mitochondria as well as knockdown of the 
essential autophagy gene, ATG7 (Figure S7A). By quantitative image analysis of two 
mitochondrial markers, TOMM20 and ATP5B, independent siRNAs targeting each of the 
following FA genes – FANCA, FANCF, FANCL, FANCD2, BRCA1 and BRCA2 – 
impaired the clearance of mitochondria after OA (Figure 7A-C, Figure S7B). Western blot 
analysis of mitochondrial proteins, HSP60 and TOMM20, confirmed a mitophagy defect in 
cells with knockdown of each of these FA genes (Figure 7D). Thus, multiple FA genes, 
including those lacking known cytoplasmic functions, are essential for mitophagy.
DISCUSSION
Our data demonstrate a previously unappreciated role for FA genes in the selective 
autophagy of viruses and damaged mitochondria. The FA pathway possesses not only a 
nuclear function in DNA damage repair but also a cytoplasmic function in selective (but not 
general) autophagy, and thereby, organellar quality control. Both of these functions may act 
in concert to protect the host genome in embryonic development, cancer and aging; 
specifically, by restraining mtROS production via the proper removal of damaged 
mitochondria, the FA pathway can limit genotoxic stress in parallel with its ability to repair 
damaged nuclear DNA, thus serving a “double-duty” role in protection of the host genome. 
Moreover, the role of FA genes in selective virophagy suggests yet another level of host 
cellular protection mediated by the FA pathway that may interplay with mitophagy, mtROS-
dependent inflammasome activation and nuclear DNA damage repair to protect organisms 
against bone marrow failure and/or cancers in the setting of infection and/or 
proinflammatory signals. Thus, the cytoplasmic functions of FA pathway genes in selective 
autophagy may coordinate with their nuclear functions to maintain cellular homeostasis.
Role of FA genes in the control of viral infection
We found that Fancc was required for virophagy of two genetically diverse viruses, 
including Sindbis virus (SIN), a single-stranded positive-sense RNA virus, and herpes 
simplex virus type 1 (HSV-1), a double-stranded DNA virus. Furthermore, Fancc−/− mice 
were more susceptible to lethal CNS infection with these two pathogens, thus identifying 
Fancc as a host innate antiviral immunity factor.
Similar to previously identified SIN virophagy factors, p62 and SMURF1 (Orvedahl et al., 
2010; Orvedahl et al., 2011), FANCC also interacts with SIN capsid protein (which is not 
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known to be ubiquitinated (Sumpter and Levine, 2011)). In addition, we found that FANCC 
was present in immunoprecipitated autophagic structures containing SIN nucleocapsids. 
Thus, FANCC may act directly in targeting SIN nucleocapsids for delivery to 
autophagosomes, although the precise molecular mechanism by which FANCC functions in 
SIN virophagy is unknown. Nonetheless, histopathological analyses of SIN-infected mouse 
brains suggest that Fancc functions similarly to core autophagy genes in protecting neurons 
against SIN infection by clearing viral antigen, thereby decreasing virus-induced neuronal 
death (Orvedahl et al., 2010).
The increased susceptibility to lethal CNS HSV-1 infection is consistent with previous 
reports indicating that the autophagy pathway, rather than interferon responses, protects 
against HSV-1 neuronal disease (Yordy and Iwasaki, 2013). The restored neurovirulence of 
an HSV-1 mutant strain lacking the ability to block autophagy, but not of another HSV-1 
strain neuroattenuated due to a mutation in a gene unrelated to autophagy, provides genetic 
evidence (Leib et al., 2000) that the protective function of Fancc in CNS neurons is mediated 
by autophagy and not other host immunity pathways.
These findings raise intriguing questions about the interrelationship between FA gene 
deficiency and viral infection, both in the context of antiviral defense and in FA 
pathogenesis. A role for FANCC in virophagy may mechanistically explain either the 
increased prevalence of certain viral infections (such as human papilloma virus [HPV] or 
SV40) in FA patients (Comar et al., 2013; Sauter et al., 2015) or the role of FA pathway 
components (such as FANCA and FANCD2) in restricting the HPV life cycle (Hoskins et 
al., 2012). Furthermore, the failure to remove aggregates of viral proteins in the setting of 
Fancc deficiency may represent an environmental trigger that functions in the 
pathophysiology of FA (Parmar et al., 2009). Defective general autophagy during single-
stranded RNA virus infection has been linked to increased mtROS production and 
proinflammatory signaling (Tal et al., 2009). Thus, FA gene deficiency could lead to 
increased generation of known and potential cytokine triggers of bone marrow failure in FA 
patients (Dufour et al., 2003; Garbati et al., 2013) through the dual effects of defective viral 
autophagic targeting (and increased accumulation of pathogen-associated molecular 
patterns) and defective removal of damaged mitochondria.
Role of FA genes in mitophagy, mtROS generation, and inflammasome activation
Our data indicate that FANCC is required for mitophagy, FANCC interacts with Parkin, and 
FANCC accumulates in damaged mitochondria in a Parkin-dependent manner. In addition, 
FANCC likely plays a role in removing damaged mitochondria independently of Parkin, as 
FANCC patient mutant fibroblasts (that lack Parkin expression) accumulated damaged 
mitochondria when treated with a mitochondrial uncoupling agent, and the brains and hearts 
of Fancc−/− mice accumulated damaged mitochondria with aging. The role of FANCC in 
Parkin-dependent mitophagy is independent of its role in genomic DNA repair, as the 
FANCC c.67delG mutant (which is as effective as WT FANCC in decreasing cytokine 
hypersensitivity but cannot rescue MMC-induced cell death or FANCD2 mono-
ubiquitination) fully restored mitophagy in FANCC-deficient cells. The mechanism by 
which FANCC functions in the targeting of diverse substrates (two unrelated viruses and 
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mitochondria), without interacting with LC3 family members, is an important area of future 
study.
We found that multiple other FA genes including FANCA, FANCF, FANCL, FANCD2, and 
BRCA1 and BRCA2 are required for Parkin-mediated mitophagy, suggesting that the FA 
pathway (rather than FANCC alone) participates in organellar homeostasis. While some FA 
proteins may regulate specific cytoplasmic functions through transcriptional effects and/or 
function directly in the cytoplasm (Du et al., 2012; Mullan et al., 2006; Preobrazhenska et 
al., 2002), some FA proteins, such as FANCD2, BRCA1 and BRCA2, have not been 
described to function directly in the cytoplasm. Besides observing co-localization of FANCC 
with damaged mitochondria in Parkin-expressing cells, we also biochemically detected 
FANCD2 in purified mitochondrial fractions. Taken together, our data suggest that the FA 
pathway, including those components downstream of the FA core complex which are part of 
nuclear DNA damage foci, functions in the cytoplasm (and potentially at the mitochondrion 
itself) to mediate the selective removal of damaged mitochondria. The precise mechanism by 
which FA pathway proteins mediate mitophagy remains to be determined. For FA proteins 
other than those in the core FA complex, we cannot rule out that defects in mitophagy with 
knockdown of protein expression are an indirect consequence of defects in genomic DNA 
damage repair.
Previous studies have indicated that FA gene-deficient cells (from humans and from 
knockout mouse models) have increased ROS, increased sensitivity to cytokine-induced cell 
death (Garaycoechea and Patel, 2014), and increased TLR-induced inflammasome activation 
(Garbati et al., 2013). Our data indicate that damaged mitochondria are a major source of 
ROS in FA-deficient cells and directly link increased mtROS generation with increased 
inflammasome activation. Furthermore, our findings are consistent with a model in which 
damaged, ROS-producing mitochondria in LPS-treated Fancc-deficient BMDMs act as 
“scaffolds” for the assembly of large ASC specks to drive pro-IL-1β processing. These 
observations provide a mechanism by which defective mitophagy (which leads to increased 
mtROS) in the setting of FA gene deficiency may lead to aberrant inflammasome activation 
and other adverse consequences of increased mtROS in patients with FA mutations. 
Although low levels of mtROS are required for many homeostatic functions (including 
control of cell growth, differentiation, death, senescence and inflammation (Hamanaka and 
Chandel, 2010)), alterations in cellular signaling pathways and genotoxic stress arising from 
dysregulated mtROS production are sufficient to drive cellular transformation and tumor 
progression in multiple cancer models (Costa et al., 2014). We speculate that the failure to 
clear damaged mitochondria may be an important driver of bone marrow failure and 
tumorigenesis in the setting of FA gene defects/mutations, either as a result of mtROS-
amplified proinflammatory cytokine production, increased cell death, and/or accumulation 
of protumorigenic mutations.
Defective mitophagy may contribute to cancers that occur in patients with mutations in FA 
pathway genes
Hematological malignancies in FA patients are thought to result from clonal expansions of 
HSCs that survive after generalized bone marrow failure (Bagby and Alter, 2006). The 
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pathogenesis of solid malignancies in these patients is not understood, but may be related to 
increased susceptibility to HPV infection (Liu et al., 2015). Consequently, as noted above, 
defects in virophagy and/or mitophagy (and downstream consequences of such defects) may 
contribute not only to bone marrow failure, but also to the increased risk of malignancy in 
FA patients. Given the essential role of autophagy in aging (Rubinzstein et al., 2011) and 
development (Mizushima and Levine, 2010), defects in selective autophagy may also 
contribute to the congenital abnormalities and the aging phenotype in FA patients.
Defective mitophagy may also play a role in tumorigenesis that occurs in the setting of non-
FA patients with driver mutations in FA genes. The mild phenotype of FA patients with the 
hereditary FANCC c.67delG mutation, which is functional in mitophagy but not in genomic 
DNA repair, argues for an important role of cytoplasmic functions of FA genes in protection 
against cancer. Of note, other studies suggest that defective mitophagy (as a result of 
mutations in genes that function in selective but not general autophagy) contributes to 
tumorigenesis (Chourasia et al. 2015). PARK2 encodes Parkin, an E3 ligase that is essential 
in mitophagy but not general autophagy (Rogov et al., 2014), and it is likely that Parkin is a 
tumor suppressor protein (Xu et al., 2014). PARK2 is deleted or mutated in many human 
cancers (including bladder, lung, breast, ovarian, and colon), and Parkin null mice display 
spontaneous liver carcinomas, increased colorectal neoplasia when crossed with Apc mutant 
mice, and increased susceptibility to radiation-induced lymphogenesis (Chourasia et al., 
2015; Poulogiannis et al., 2010). These observations, coupled with our findings that multiple 
FA pathway genes (including the well-characterized tumor suppressors commonly mutated 
in familial breast and ovarian cancer, BRCA1 and BRCA2) function in mitophagy, support 
the hypothesis that FA gene mutations may promote cancer through their essential roles in 
mitophagy in addition to through their roles in genomic DNA damage repair.
Conclusion
Our results reveal a previously undescribed cytoplasmic role for FA pathway genes, 
specifically in the cellular homeostasis pathway involving selective autophagy of unwanted 
cargo. These findings provide new directions for investigation into the pathophysiology of 
not only FA and cancers that arise from driver mutations of FA genes, but also of congenital 
abnormalities, infectious diseases, aging and other processes in which the autophagy 
pathway plays an important role (Levine and Kroemer, 2008; Mizushima and Komatsu, 
2011; Rubinsztein et al., 2011).
EXPERIMENTAL PROCEDURES
Primary Murine Cells and HeLa FANCCKO Cells
Primary murine embryonic fibroblasts (MEFs) were established from Fancc+/+ and Fancc−/− 
mice at day e13.5. Primary murine bone marrow-derived macrophages (BMDMs) were 
generated from Fancc+/+ and Fancc−/− mice by culturing cells from mouse femurs and tibia 
in DMEM supplemented with 20% FBS and 30% L929 cell-conditioned media. HeLa 
FANCCKO cells were generated by CRISPR/Cas9 genome editing at the Washington 
University Genome Engineering and iPSC center (St. Louis, MO). See Supplemental 
Experimental procedures for details.
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LC3 and TOMM20 IP’s
HeLa cells were mechanically lysed and fractionated using the QProteome mitochondria 
isolation kit (Qiagen) according to the manufacturer’s instructions. Microsomal + 
mitochondrial fractions were used to isolate LC3-positive membranous structures in cells 
infected with SIN strain SVIA by performing IP with an anti-LC3 antibody. Mitochondrial 
fractions were used to isolated purified mitochondria from cells treated DMSO- or OA-
treated (4 hr) by performing IP with an anti-TOMM20 antibody. See Supplemental 
Experimental procedures for details.
Mouse Strains and Animal Studies
See Supplemental Experimental procedures for details.
siRNAs and qRT-PCR
See Supplemental Experimental procedures and Supplemental Table 1 for details.
Light and Electron microscopy, Quantitative Image Analyses, and Flow cytometry
See Supplemental Experimental procedures for details.
Mammalian Cells, Viruses, Plasmids, Antibodies and Chemicals
See Supplemental Experimental procedures for details.
Western Blot Analyses, Co-Immunoprecipitations and IL-1β ELISA
See Supplemental Experimental procedures for details.
Statistical Analyses
Log-rank tests were used to analyze all mortality studies. t-tests were used for comparisons 
of means of normally distributed data and Mann-Whitney U tests were used for comparison 
of non-normally distributed data. Chi-square analysis was used to determine difference 
between groups in ASC speck and flow cytometry experiments.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Fancc is Required for Autophagic Targeting of Genetically Distinct Viruses, but Not for 
Starvation-Induced Autophagy
(A) Western blot of LC3-I/LC3-II in primary murine embryonic fibroblasts (MEFs) during 
growth in normal (starvation −) or EBSS (starvation +) medium for 4 hr +/− 100 nM 
bafilomycin A1 (Baf A1).
(B) Western blot of p62 in MEFs in culture conditions as in (A).
(C) Quantification of GFP-LC3 puncta (autophagosomes) in Fancc+/+/GFP-LC3 and 
Fancc−/−/GFP-LC3 MEFs during growth in normal or starvation medium for 4 hr +/− 100 
nM Baf A1. Bars are mean ± SEM for triplicate samples (>100 cells analyzed per sample by 
an observer blinded to experimental condition). NS, not significant; *, P<0.05; t-test.
(D) EM of autophagic structures in MEFs during growth in normal or starvation medium 
(EBSS, 4 hr). White arrows indicate autolysosomes. Scale bars, 1 μm.
(E and F) Representative light micrographs of images (E) used for quantification (F) of 
colocalization of SIN/mCherry.capsid and GFP-LC3 in MEFs infected with SIN 
mCherry.capsid/GFP-LC3 (multiplicity of infection [MOI] = 2.5 plaque-forming units 
[PFUs], 18 hr). In (E), white arrows denote representative colocalized mCherry.capsid and 
GFP-LC3 signal. Scale bars, 10 μm. In (F), bars are mean ± SEM for triplicate samples (> 
50 cells analyzed per sample by an observer blinded to experimental condition). *, P<0.05; 
t-test.
(G) Western blot of FANCC in HeLa WT and HeLa FANCCKO cells.
(H) EM of immunoprecipitated autophagic structures using an anti-LC3 antibody from 
HeLa FANCCKO cells transduced with a lentivirus expressing FANCC-Flag and infected 
with SIN strain SVIA (MOI = 5, 6 hr). White arrows indicate SIN nucleocapsids inside 
autolysosomes. Asterisks indicate dynabeads used for IP. Scale bars, 200 nm.
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(I) Western blot of indicated proteins in anti-LC3 immunoprecipitates (representative 
electron microscopes shown in (H)) from HeLa FANCCKO cells transduced with lentivirus 
vector (HeLa FANCCKO/vector) or lentivirus expressing FANCC-Flag (HeLa FANCCKO/
FANCC) and infected with SIN strain SVIA (MOI = 5, 6 hr).
(J) Western blot of indicated proteins in control and SIN-infected HeLa FANCCKO/FANCC 
cells subjected to anti-LC3 IP as in (H-I) and then 30 min digestion on ice with 2.5 ng/ml 
proteinase K +/− 0.5% triton X-100.
(K) Co-IP of SIN capsid protein with FANCC-Flag in HeLa FANCCKO/vector (Vector) or 
HeLa FANCCKO/FANCC (FANCC) cells infected with SIN strain dsTE12Q (MOI = 5, 6 
hr).
(L) Representative EMs of MEFs infected with HSV-1 ICP34.5Δ68-87 (MOI = 5, 6 hr). 
White arrows denote representative HSV-1 nucleocapsids being degraded inside 
autolysosomes. Black arrows denote representative HSV-1 nucleocapsid (bottom left) or 
assembled HSV-1 virion (bottom right) inside the cytoplasm. Scale bars, 200 nm for large 
panels; 50 nm for insets.
(M) Quantification of HSV-1 nucleocapsids and virions within autophagosomes or 
autolysosomes (inside autophagic structures) or free within the cytoplasm (cytoplasmic) in 
experiment shown in (L). Twenty-five HSV-1-infected cell profiles were counted per 
genotype by an observer blinded to experimental conditions. **, P<0.01; Mann-Whitney U 
test.
In A-C, E and F, and I-K, similar results were observed in three independent experiments.
See also Figure S1.
Sumpter et al. Page 18
Cell. Author manuscript; available in PMC 2017 May 05.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 2. Fancc is Required for Host Defense against SIN and HSV-1 CNS Viral infections
(A) Survival of 7 day-old mice infected intracerebrally (i.c.) with 1000 PFUs SIN strain 
dsTE12Q. Results shown represent combined survival for independent infections of more 
than 5 litters (similar results obtained for each infection). P-value (log-rank test) and number 
of mice per genotype indicated in graph.
(B and C) Quantitation of TUNEL-positive area per brain section (B) and representative 
light micrographs (C) after infection of 7 day-old mice of indicated genotype infected as in 
(A). Bars represent median value for each group. *, P<0.05; Mann-Whitney U test. Scale 
bars, 500 μm.
(D) Survival of 6-8 week-old mice infected i.c. with 5x104 PFUs HSV-1 ICP34.5Δ68-87. 
Results shown represent combined survival data combined from three independent infections 
(similar results obtained for each infection). P-value (log-rank test) and number of mice per 
genotype indicated in graph.
(E and F) Quantitation of TUNEL-positive area per brain section (E) and representative 
light micrographs (F) at indicated time points of 2 month-old mice infected as in (D). Bars 
represent median value for each group. **, P<0.01; Mann-Whitney U test. Scale bars, 500 
μm.
See also Figure S2.
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Figure 3. FANCC is Required for the Clearance of Damaged Mitochondria in vitro and in vivo
(A and B) Mitophagy analysis in FANCCKO/FANCC (WT) or FANCCKO/vector 
(FANCCKO) cells stably expressing HA-Parkin assessed by clearance of TOMM20 (A) or 
ATP5B (B). Cells were treated with OA (Oligomycin, 2.5 μM; Anitmycin A, 250 nM) for 8 
hr prior to imaging and automated image analysis. Left, representative images of 
immunoflourescence staining. Right, quantitative image analysis. Shown are box plots of at 
least 150 cells analyzed per condition. Similar results were observed in three independent 
experiments. ***, P<0.001, Mann-Whitney U-test. Scale bars, 20 μm.
(C) Mitophagy analysis by western blot detection of HSP60, COXIV or TOMM20 in WT or 
FANCCKO cells stably expressing HA-Parkin and treated +/− OA for 8 hr.
(D) EM analysis of brain (cerebellum) or heart tissue (left ventricle) from 1 year-old mice. 
Shown are images from one representative mouse per genotype. Similar results were 
observed in 6 mice per genotype. White arrows indicate damaged mitochondria. Scale bars, 
1 μm.
See also Figure S3.
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Figure 4. FANCC Interacts with Parkin and Increases its Localization to Mitochondria in a 
Parkin-Dependent Fashion
(A) Mitochondrial colocalization of FANCC-Flag in HeLa FANCCKO/FANCC/Parkin cells 
treated with DMSO or OA for 8 hr, and subjected to immunofluorescence staining to detect 
TOMM20 and FANCC-Flag. Similar results were observed in three independent 
experiments. Scale bars, 20 μm.
(B) Representative light micrographs of immunofluorescence staining of HeLa FANCCKO 
cells transiently transfected with FANCC-Flag and mCherry-Parkin for 24 hr and then 
treated with DMSO or OA for 4 hr. Scale bars, 10 μm.
(C) Co-IP of Parkin with FANCC-Flag in HeLa FANCCKO cells transiently transfected with 
mCherry-Parkin and vector or FANCC-Flag for 24 hr.
(D) Co-IP of Parkin with endogenous FANCA in HeLa WT/Parkin cells +/− OA for 4 hr.
(E) EMs of immunoprecipitated mitochondria using an anti-TOMM20 antibody from HeLa 
WT/Parkin cells +/− OA for 4 hr. Black arrowhead, ruptured mitochondrial membrane.
(F) Western blot of indicated proteins in TOMM20 immunoprecipitates from HeLa WT/
Parkin or HeLa FANCCKO/Parkin cells +/− OA for 4 hr. Input, crude mitochondrial 
fractions. MMC, whole cell lysate from HeLa FANCCKO/FANCC/Parkin cells treated with 
MMC for 24 hr is included as a loading control to show FANCD2 mono-ubiquitination. For 
mitochondrial samples, protein loading was normalized by densitometry for HSP60 in crude 
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mitochondrial fractions (input). Left and right gel panels for each protein are cropped from 
the same gel image.
See also Figure S4.
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Figure 5. FANCC Deficiency in Patient Fibroblasts and Murine BMDMs Results in Abnormal 
mtROS Production
(A) FANCC-deficient patient fibroblasts are defective in FA core complex activity assessed 
by western blot of MMC-induced FANCD2 mono-ubiquitination. FANCC-deficient patient 
fibroblasts were transduced with a FANCC-expressing retrovirus (WT FANCC) or a vector 
control retrovirus (Vector) and then treated with 1 μM MMC for 24 hr.
(B) Mitochondrial morphology in WT FANCC or vector transduced immortalized patient 
fibroblasts. Cells were treated with 10 μM CCCP for 24 hr prior to immunofluorescence 
staining with anti-TOMM20. White arrow, representative cell with diffuse accumulation of 
fragmented mitochondria. Scale bars, 20 μm.
(C) MtROS production assessed by flow cytometric analysis of MitoSOX fluorescence 
levels in WT FANCC or vector transduced immortalized patient fibroblasts treated with 
DMSO or 10 μM CCCP for 24 hr.
(D) MtROS production assessed by flow cytometric analysis of MitoSOX fluorescence 
levels in primary BMDMs from Fancc+/+ and Fancc−/− mice. BMDMs were treated with 
LPS (100 ng/mL, 4 hr) +/− ATP (5 mM) during the final 30 min prior to flow cytometric 
analysis.
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(E) Inflammasome activation measured by IL-1β levels in supernatants of BMDMs of 
treated with LPS (100 ng/mL, 4 hr) +/− ATP (5 mM) and MitoTEMPO (500 μM) for the 
final 30 min of LPS treatment. Bars are mean ± SEM for triplicate samples. *P<0.05; t-test.
(F) Inflammasome activation measured by ASC speck formation in BMDMs treated with 
LPS (100 ng/mL, 4 hr), LPS and ATP (5 mM for final 15 min of LPS), or LPS, ATP and 
MitoTEMPO (500 μM for the final hr of LPS) prior to immunostaining and automate image 
analysis. At least 500 cells were analyzed per condition. **, P<0.01, ****, P<0.0001, chi-
square test.
(G-H) Representative images of ATP5B immunoflourescence staining (G) and quantitation 
of cytoplasmic ATP5B puncta (H) in LPS-treated (100 ng/mL, 4 hr) BMDMs. Shown in (H) 
are box plots of at least 450 cells analyzed per condition. ****, P<0.0001, Mann-Whitney 
U-test. Scale bars, 10 μm.
(I) Representative light micrographs of immunofluorescence staining of ASC and ATP5B in 
Fancc+/+ and Fancc−/− BMDMs treated with LPS + ATP or LPS + ATP + MT as described 
in (F). Scale bars, 5 μm.
For (A-I), similar results were observed in three independent experiments. MT, 
mitoTEMPO.
See also Figure S5.
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Figure 6. The Mitophagy Function of FANCC is Genetically Dissociated from its Role in Nuclear 
DNA Damage Repair
(A) FA core complex activity assessed by western blot of MMC (1 μM, 24 hr)-induced 
FANCD2 mono-ubiquitination in parental HeLa cells (WT) or HeLa FANCCKO cells 
transduced with indicated FANCC vector. A longer exposure of FANCC reveals FANCC-
Flag protein expression in lanes 4-8 (data not shown).
(B) Cytokine-induced cell death in HeLa FANCCKO cells transduced with indicated FANCC 
vector. Cells were treated with TNF-α and IFN-γ (10 ng/mL each, 48 hr) and cell death was 
measured by flow cytometric analysis of 7-AAD (a vital dye) staining. ****, P<0.0001, chi-
square test.
(C) MMC-induced cell death in HeLa FANCCKO cells transduced with indicated FANCC 
vector. Cells were treated with MMC (1 μM) for 48 hr and cell death was measured by flow 
cytometric analysis of 7-AAD (a vital dye) staining. ****, P<0.0001, chi-square test.
(D) Representative images of TOMM20 (upper panels) or ATP5B (lower panels) 
immunoflourescence staining of parental HeLa/Parkin cells (WT) or HeLa FANCCKO/
Parkin cells transduced with indicated FANCC vector treated with OA for 8 hr prior to 
imaging and automated image analysis (D). Scale bars, 10 μm.
(E) Quantitation of cytoplasmic TOMM20 puncta or ATP puncta in cells treated as shown in 
representative images in (D). Shown are box plots of at least 150 cells analyzed per 
condition. ****, P<0.0001, Mann-Whitney U-test.
(G) Mitophagy analysis in HeLa FANCCKO/Parkin cells transduced with indicated FANCC 
vector assessed by western blot of HSP60 or TOMM20 proteins in cells +/− OA for 8 hr.
For (A-F), similar results were observed in three independent experiments.
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Figure 7. Multiple FA Genes are Required for Mitophagy
(A) Representative light micrographs of images used for quantification of TOMM20 (left 
panels) in (B) and ATP5B (right panels) clearance in (C) in HeLa/Parkin cells transfected 
with indicated siRNAs and 48 hr later treated with OA for 8 hr. Scale bars, 20 μm.
(B-C) Quantitation of cytoplasmic TOMM20 (B) or ATP5B (C) puncta in cells transfected 
with indicated siRNAs and treated as in (A). Shown are box plots of at least 150 cells 
analyzed per condition. Similar results were observed in three independent experiments. **, 
P<0.01, ****, P<0.0001; Mann-Whitney U-test.
(D) Mitophagy analysis in HeLa FANCCKO/Parkin cells transfected with indicated siRNA 
assessed by western blot of indicated proteins +/− OA for 8 hr. See also Figure S7.
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